Literature DB >> 26854431

Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines.

Rick Morrison1, Jasim M A Al-Rawi2, Ian G Jennings3, Philip E Thompson4, Michael J Angove5.   

Abstract

The synthesis of 6-aryl, 8- aryl, and 8-aryl-6-chloro-2-morpholino-1,3-benzoxazines with potent activity against PI3K and DNA-PK is described. Synthesis of thirty one analogues was facilitated by an improved synthesis of 3-bromo-2-hydroxybenzoic acid 13 by de-sulphonation of 3-bromo-2-hydroxy-5-sulfobenzoic acid 12 en route to 2-methylthio-substituted-benzoxazine intermediates 17-19. From this series, compound 20k (LTURM34) (dibenzo[b,d]thiophen-4-yl) (IC50 = 0.034 μM) was identified as a specific DNA-PK inhibitor, 170 fold more selective for DNA-PK activity compared to PI3K activity. Other compounds of the series show markedly altered selectivity for various PI3K isoforms including compound 20i (8-(naphthalen-1-yl) a potent and quite selective PI3Kδ inhibitor (IC50 = 0.64 μM). Finally, nine compounds were evaluated and showed antiproliferative activity against an NCI panel of cancer cell lines. Compound 20i (8-(naphthalen-1-yl) showed strong anti-proliferative activity against A498 renal cancer cells that warrants further investigation.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-cancer activity; DNA-PK; PI3K; Suzuki coupling synthesis of 8- and 6-aryl-2-morpholino-1,3-benzoxazines

Mesh:

Substances:

Year:  2016        PMID: 26854431     DOI: 10.1016/j.ejmech.2016.01.042

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

Review 1.  Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.

Authors:  Yoshihisa Matsumoto
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

2.  Synthesis of 4H-Benzo[e][1,3]oxazin-4-ones by a Carbonylation-Cyclization Domino Reaction of ortho-Halophenols and Cyanamide.

Authors:  Linda Åkerbladh; Shiao Y Chow; Luke R Odell; Mats Larhed
Journal:  ChemistryOpen       Date:  2017-08-16       Impact factor: 2.911

3.  SCFβ-TrCP-mediated degradation of TOP2β promotes cancer cell survival in response to chemotherapeutic drugs targeting topoisomerase II.

Authors:  Jianfeng Shu; Danrui Cui; Ying Ma; Xiufang Xiong; Yi Sun; Yongchao Zhao
Journal:  Oncogenesis       Date:  2020-02-03       Impact factor: 7.485

4.  Cycloaddition of 4-Acyl-1H-pyrrole-2,3-diones Fused at [e]-Side and Cyanamides: Divergent Approach to 4H-1,3-Oxazines.

Authors:  Ekaterina E Khramtsova; Aleksandr D Krainov; Maksim V Dmitriev; Andrey N Maslivets
Journal:  Molecules       Date:  2022-08-17       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.